| Followers | 17 |
| Posts | 919 |
| Boards Moderated | 0 |
| Alias Born | 04/28/2018 |
Tuesday, August 29, 2023 9:40:21 AM
Recent NVCR News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 12:01:24 PM
- Novocure Appoints Company President Frank Leonard as Chief Executive Officer • Business Wire • 12/01/2025 12:00:00 PM
- Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference • Business Wire • 11/26/2025 12:00:00 PM
- Novocure to Participate in 2025 Jefferies Global Healthcare Conference • Business Wire • 11/12/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/07/2025 09:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:10:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:09:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2025 11:00:11 AM
- Novocure Reports Third Quarter 2025 Financial Results • Business Wire • 10/30/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 10:59:41 AM
- Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress • Business Wire • 10/15/2025 11:00:00 AM
- Novocure to Report Third Quarter 2025 Financial Results • Business Wire • 10/01/2025 11:00:00 AM
- Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting • Business Wire • 09/29/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2025 11:00:10 AM
- Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC) • Business Wire • 09/15/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2025 11:10:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2025 11:03:12 AM
- Novocure Announces Upcoming Investor Events • Business Wire • 08/28/2025 11:00:00 AM
- Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain • Business Wire • 08/25/2025 11:00:00 AM
- Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer • Business Wire • 08/20/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2025 08:33:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2025 11:02:21 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/24/2025 11:01:32 AM
- Novocure Reports Second Quarter 2025 Financial Results • Business Wire • 07/24/2025 11:00:00 AM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy • HLYK • Dec 8, 2025 8:00 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
